Literature DB >> 26046084

Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.

Markus Maeurer1, Martin Rao1, Alimuddin Zumla1.   

Abstract

Entities:  

Year:  2015        PMID： 26046084      PMCID： PMC4437944          DOI： 10.3978/j.issn.2305-5839.2015.03.65

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  46 in total

1.  Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.

Authors:  Seung-Jung Kee; Yong-Soo Kwon; Yong-Wook Park; Young-Nan Cho; Sung-Ji Lee; Tae-Jong Kim; Shin-Seok Lee; Hee-Chang Jang; Myung-Geun Shin; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

Review 2.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

Authors:  Hergen Spits; Tom Cupedo
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 3.  Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains.

Authors:  Ida Parwati; Reinout van Crevel; Dick van Soolingen
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

Review 4.  Gammadelta T cells and Mycobacterium tuberculosis.

Authors:  W H Boom
Journal:  Microbes Infect       Date:  1999-03       Impact factor: 2.700

5.  Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection.

Authors:  Alimuddin Zumla; Rifat Atun; Markus Maeurer; Peter Mwaba; Zhenkun Ma; Justin O'Grady; Matthew Bates; Keertan Dheda; Michael Hoelscher; John Grange
Journal:  Trop Med Int Health       Date:  2011-01       Impact factor: 2.622

6.  Interleukin-32: a cytokine and inducer of TNFalpha.

Authors:  Soo-Hyun Kim; Sun-Young Han; Tania Azam; Do-Young Yoon; Charles A Dinarello
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

7.  Metformin as adjunct antituberculosis therapy.

Authors:  Amit Singhal; Liu Jie; Pavanish Kumar; Gan Suay Hong; Melvin Khee-Shing Leow; Bhairav Paleja; Liana Tsenova; Natalia Kurepina; Jinmiao Chen; Francesca Zolezzi; Barry Kreiswirth; Michael Poidinger; Cynthia Chee; Gilla Kaplan; Yee Tang Wang; Gennaro De Libero
Journal:  Sci Transl Med       Date:  2014-11-19       Impact factor: 17.956

Review 8.  Cytotoxic therapy for severe avian influenza A (H5N1) infection.

Authors:  Jan-Inge Henter; Chun-Bong Chow; Chi-Wai Leung; Yu-Lung Lau
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 10.  Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials.

Authors:  Thomas A Rasmussen; Martin Tolstrup; Anni Winckelmann; Lars Østergaard; Ole S Søgaard
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452
View more
  2 in total

1.  Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.

Authors:  Karla D Passalacqua; Marie-Eve Charbonneau; Nicholas J Donato; Hollis D Showalter; Duxin Sun; Bo Wen; Miao He; Hanshi Sun; Mary X D O'Riordan; Christiane E Wobus
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  The urinary and serum levels of IL-32 in children with febrile urinary tract infections.

Authors:  Alireza Rafiei; Hamid Mohammadjafari; Ayat Ahifar; Abbas Alipour; Araz Mohammad Mirabi
Journal:  Future Sci OA       Date:  2017-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.